DEA Regulations
Drug Enforcement Administration regulations in the United States that govern the prescribing of controlled substances, including ADHD stimulant medications. These regulations affect how ADHD medications can be prescribed via telehealth.
Overview
DEA regulations in the US govern how controlled substances like ADHD medications can be prescribed, affecting telehealth options.
Detailed Description
The Drug Enforcement Administration (DEA) in the United States regulates controlled substances, including ADHD stimulant medications. These regulations affect how medications can be prescribed, including via telehealth. During the COVID-19 pandemic, some regulations were relaxed to allow telehealth prescribing, but regulations vary by state and may require in-person visits for initial prescriptions or controlled substance renewals.
How This Relates to ADHD
DEA regulations affect how US residents can access ADHD medications, particularly via telehealth. Understanding these regulations is important.
Treatment and Management
DEA regulations may affect your ability to get ADHD medications via telehealth. Check with providers about current regulations in your state.
Examples
- •Some states require in-person visits for initial stimulant prescriptions
- •Regulations changed during COVID-19 pandemic
Resources
Learn more about ADHD diagnosis and treatment in the US. Our US diagnosis guide provides information about regulations and access.
Take Action
Understanding DEA Regulations is just the beginning. Take our free ADHD assessment or explore diagnosis options in your area.
Explore More
Free ADHD Assessment
Take our validated ASRS-based screening tool to understand your symptoms.
ADHD Diagnosis Guides
Find country-specific information about getting an ADHD diagnosis.
ADHD Screeners
Explore different ADHD screening tools and assessments.
ADHD Resources
Access comprehensive ADHD resources, guides, and information.